As part of the Covid-19 policy solution, banks are benefiting from an easing of regulatory requirements. While this is generally supportive for banks’ fundamentals, risks for AT1 investors could increase.
Regulators have responded quickly to ensure that banks are able to support the economy, taking measures to increase the amount of capital available to banks, easing requirements and exercising flexibility to soften the impact of expected credit losses.
“While these measures are generally supportive of bank fundamentals, the implications for AT1 investors are more nuanced,” said Pauline Lambert, executive director in the financial institutions team of Scope Ratings and author of the latest AT1 quarterly, published today.
“The easing of capital requirements is helpful to an extent. While drawing down on capital buffers is permitted and even encouraged, breaching the combined capital buffer still has consequences.”
For AT1 investors, the most relevant relaxations in capital requirements have been the removal or reduction of countercyclical and systemic risk buffers in countries where these had been actively used before Covid-19: the countercyclical buffer in the UK and Norway and the systemic risk buffer in the Netherlands and Finland.
Meanwhile, strong regulatory guidance to restrict dividends and bonuses, with European AT1 issuers complying in some manner, has strengthened banks’ solvency positions. But this has raised concerns about AT1 securities.
“This supervisory decisiveness raises questions about the likelihood of regulatory intervention in the payment of AT1 coupons,” Lambert cautioned.
For now, major European AT1 issuers generally remain sound, so Scope sees limited risks. However, as the impacts of Covid-19 persist and issuer fundamentals deteriorate due to losses and capital depletion, the risk of non-payment will increase.